Jean-Marc Pardonge has been appointed as the new President of Aptar Pharma’s Prescription Division, leaders in the development and manufacturing of nasal and pulmonary drug delivery devices.
Pardonge succeeds Salim Haffar, and also becomes the new General Manager of Aptar Stelmi (the Stelmi company was recently acquired by Aptargroup). After graduating from the French ENSAM engineering school (Ecole Nationale Supérieure d’Arts et Métiers), Pardonge joined Aptar Pharma Prescription Division in 2000 as R&D Manager. He was promoted to the position of Vice President R&D in 2003. In January 2010, he became President of Global Market Development (GMD) of Aptar Pharma’s Prescription Division. In this role, he managed and coordinated worldwide activities which included Scientific and Regulatory Affairs, Business Development, Communi-cation, Engineering, Innovation, Marketing, Projects, and R&D. Aptar Pharma’s Prescription Division will leverage Pardonge’s in-depth knowledge of both the pharmaceutical market and the Division’s customers to take full advantage of market opportunities for growth.
EP News Bureau – Mumbai
